Alex Shakhov

Sr. Manager Clinical Trial Liaison, Global Site Management

PANELIST

‍"Join me, alongside experts from Novo Nordisk, George Clinical, IQVIA and Oximio, on March 18th, 2025, at 15:00 UTC for the UNFOLD CT XChange panel discussion. on Opportunities VS Challenges for Patient Recruitment in EECCA, moderated by Diana Matiashvilli, Founder & CEO of Paspigioni."

‍

Tamar Bolkvadze

Pavlo Garkaviy

Back To Overview page Back To Event Overview Back To Event Overview

Regeneron is a leading biotechnology company dedicated to inventing, developing and commercialising life-transforming treatments for serious diseases

With 19 years of experience in clinical development, Alex brings a wealth of knowledge across all study phases. He earned his MD from St. Petersburg Pavlov State Medical University in Russia. Throughout his career, Alex has worked in various therapeutic areas, including oncology, neurology, rheumatology, endocrinology, pulmonology, gastroenterology, and rare diseases.

His true passion lies in oncology, where he is driven not only by the pursuit of treatments but by the goal of finding a cure. Alex is multilingual, fluent in Russian, with a basic understanding of French and Mandarin.

Outside of his professional life, Alex enjoys sailing, appreciating both the challenges and the tranquility that come with life on the open sea.

‍